Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.
about
The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated ProteinsPhase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupIGF-II dependent autocrine growth in cell lines derived from renal tumours of childhood.Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumorsPhase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.Suppression of insulin-like growth factor type I receptor by a triple-helix strategy inhibits IGF-I transcription and tumorigenic potential of rat C6 glioblastoma cells.Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene productInhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.Structural analysis of the human insulin-like growth factor-II P3 promoter.Type 1 insulin-like growth factor receptor targeted therapies in pediatric cancer.
P2860
Q28088661-A0820004-08B2-4BD8-87D5-35E7B4CD97BCQ33398810-3D7819A4-9B83-48B5-B097-9C21FB20136CQ33839585-C5DD348D-0B64-49AD-A466-77CBCB124E4EQ34185775-18EE2D33-CA52-46A5-ACBD-78884B182958Q35833830-B54A60FF-5463-4F2F-AA56-D8BAA6DAA390Q35880614-E170529C-C686-4C2A-A48E-22D3115D22D8Q36160109-1AA53BE8-51D0-4B33-82A4-B48CB65E59DBQ36378010-DA43CAC6-EE1D-4CA1-8970-E44D4ABAFE14Q36552308-CE6F9F9F-655A-4FA3-BFC3-121B6B327037Q37498347-C883FC4E-97C2-467B-BA13-A9E8E06AD449Q41844735-D14E9070-6C16-43BB-9E24-A4147F51C520Q43144913-D7F5A2A1-E254-46E6-8163-2D69BD30EFE7
P2860
Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Antibody to type I insulinlike ...... n culture and in athymic mice.
@ast
Antibody to type I insulinlike ...... n culture and in athymic mice.
@en
type
label
Antibody to type I insulinlike ...... n culture and in athymic mice.
@ast
Antibody to type I insulinlike ...... n culture and in athymic mice.
@en
prefLabel
Antibody to type I insulinlike ...... n culture and in athymic mice.
@ast
Antibody to type I insulinlike ...... n culture and in athymic mice.
@en
P2093
P2860
P1476
Antibody to type I insulinlike ...... n culture and in athymic mice.
@en
P2093
A J Garvin
K A Robinson
R Furlanetto
T S Gramling
P2860
P304
P407
P577
1989-12-01T00:00:00Z